Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-2 of 2
Keywords: Senile dementia of Alzheimer type
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Tokumi Fujikawa, Terumichi Takahashi, Akiko Kinoshita, Hiroaki Kajiyama, Akiko Kurata, Hidehisa Yamashita, Shigeto Yamawaki
Journal:
Neuropsychobiology
Neuropsychobiology (2004) 49 (4): 201–204.
Published Online: 06 May 2004
..., instructions or products referred to in the content or advertisements. Behavioral and psychological symptoms of dementia Senile dementia of Alzheimer type Extrapyramidal symptoms Quetiapine Risperidone Olanzapine Pharmacopsychiatry Editor: B. Saletu (Vienna) Original Paper Neuropsychobiology...
Journal Articles
Journal:
Neuropsychobiology
Neuropsychobiology (1992) 25 (1): 24–28.
Published Online: 01 January 1992
...C. Villardita; S. Grioli; C. Lomeo; C. Cattaneo; J. Parini The cognitive and behavioral effects and the safety of oxiracetam therapy during a placebo-controlled trial and the relevant follow-up up to 1 year in patients with senile dementia of Alzheimer type (SDAT) and multi-infarct dementia (MID...